USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name:
IMBIO, LLC
Address:
227 COLFAX AVE N, STE 148
MINNEAPOLIS, MN 55405-1439
Phone:
(612) 530-7360
URL:
EIN:
120582179
DUNS:
078397649
Number of Employees:
11
Woman-Owned?:
No
Minority-Owned?:
No
HUBZone-Owned?:
No

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $294,245.00 2
SBIR Phase II $3,326,405.00 2

Award List:

Interactive Training for Parents of Young Children with Developmental Delays

Award Year / Program / Phase:
2013 / SBIR / Phase I
Award Amount:
$144,146.00
Agency:
HHS
Principal Investigator:
Ryan M. Chamberlain – 612-626-2001
Abstract:
DESCRIPTION (provided by applicant): Despite remarkable advances in cancer detection and treatment, the disease continues to be a leading cause of mortality in the US accounting for 23% of all deaths in 2011. Cancer of the breast and prostate are by far the most common forms diagnosed in US women… More

Raman/OCT probe for real-time assessment of oral health status

Award Year / Program / Phase:
2013 / SBIR / Phase I
Award Amount:
$150,099.00
Agency:
HHS
Principal Investigator:
Ryan M. Chamberlain – 612-626-2001
Abstract:
DESCRIPTION (provided by applicant): Chronic obstructive pulmonary disease (COPD) is a highly and increasingly prevalent disorder characterized by incomplete reversible airflow limitations. It is presently the third leading cause of death in the US, with over 13 million peopl suffering from the… More

Commercialization of the Shutter-Speed Model for Dynamic MRI in Cancer Diagnosis

Award Year / Program / Phase:
2014 / SBIR / Phase II
Award Amount:
$1,639,350.00
Agency:
HHS
Principal Investigator:
Ryan M. Chamberlain – 612-520-7360
Abstract:
DESCRIPTION (provided by applicant): Despite remarkable advances in cancer detection and treatment, the disease continues to be a leading cause of mortality in the US accounting for 23% of all deaths in 2011. Cancer of the breast and prostate are by far the most common forms diagnosed in US women… More

CT-based Biomarker for Diagnosis of COPD Phenotypes and Disease Progression

Award Year / Program / Phase:
2014 / SBIR / Phase II
Award Amount:
$1,687,055.00
Agency:
HHS
Principal Investigator:
Ryan M. Chamberlain – 612-520-7360
Abstract:
DESCRIPTION (provided by applicant): Chronic obstructive pulmonary disease (COPD) is a highly and increasingly prevalent disorder characterized by incomplete reversible airflow limitations. It is presently the third leading cause of death in the US, with over 13 million peopl suffering from the… More